首页|淄博市难治性幽门螺杆菌耐药性及耐药基因分析

淄博市难治性幽门螺杆菌耐药性及耐药基因分析

扫码查看
目的 比较细菌培养法和核酸检测法对胃黏膜组织样本中幽门螺杆菌(Helicobacter pylori,Hp)的检出率,通过检测Hp对克拉霉素和左氧氟沙星的耐药基因型与"金标准"培养法的耐药表型进行一致性比较,从而评估Hp对克拉霉素和左氧氟沙星耐药性快速检测的价值.方法 以2022年1月—2023年2月在淄博市第一医院消化内科就诊的呼气试验阳性且已经经过一次或以上四联根除Hp治疗的84例患者为研究对象,取胃黏膜组织样本进行Hp培养、Hp核酸检测和克拉霉素、左氧氟沙星耐药基因检测,并对分离菌株进行耐药表型检测.结果 84例胃黏膜组织样本,培养法检出Hp阳性60例(71.43%),阴性24例(28.57%),核酸检测法检出Hp阳性79例(94.05%),阴性5例(5.95%),两种方法检测Hp阳性率比较,差异有统计学意义(P<0.001);60例培养阳性的Hp,对甲硝唑的耐药率最高为88.3%,其次是对左氧氟沙星和克拉霉素,耐药率均为73.3%,对四环素和呋喃唑酮的耐药率均为1.7%,未发现对利福平和阿莫西林耐药菌株,敏感率由高到低依次是对利福平、阿莫西林、呋喃唑酮、四环素、克拉霉素、左氧氟沙星、甲硝唑;核酸检测法检测Hp耐克拉霉素基因23S rDNA突变位点,与药敏结果比较,一致率是91.67%,核酸检测耐左氧氟沙星基因突变位点261A和271T,与药敏结果比较,一致率为96.67%.结论 淄博地区检出的Hp对克拉霉素和左氧氟沙星的耐药率均已超过70%,不建议将其用于首次根除治疗失败的患者治疗.核酸检测法检测Hp和耐药基因与培养法一致性较高,可以用于对克拉霉素和左氧氟沙星的耐药性快速检测.
Drug resistance and resistance gene analysis of Helicobacter pylori in Zibo City
Objective The detection rate of Helicobacter pylori(Hp)in gastric mucosal tissue samples was compared between the bacterial culture method and the nucleic acid detection method.The consistency of the resistance genotypes of Hp to clarithromycin and levofloxacin was compared with that of the"gold standard"culture method to evaluate the value of rapid detection for Hp to clarithromycin and levofloxacin resistance.Methods A total of 84 patients with positive breath tests and one or more quadruple eradications of Hp from January 2022 to February 2023 in the Department of Gastroenterology,Zibo First Hospital,were enrolled in the study.Gastric mucosal tissue samples were taken for Hp culture,Hp nucleic acid detection,clarithromycin and levofloxacin resistance gene detection,and isolated strains were entered testing for resistant phenotypes is performed.Results Of the 84 gastric mucosal tissue samples,60(71.43%)positive and 24(28.57%)negative Hp were detected by the culture method,while 79(94.05%)positive and 5(5.95%)negative Hp were detected by the nucleic acid detection method,and the difference was statistically significant(P<0.001).The highest resistance rate to metronidazole was 88.3%in 60 positive Hp cultures,followed by levofloxacin and clarithromycin(73.3%),tetracycline and furazolidone(1.7%).No strains resistant to rifampicin and amoxicillin were found,and the susceptibility to antibiotics from high to low was rifampicin,amoxicillin,furazolidone,tetracycline,clarithromycin,levofloxacin and metronidazole.The consistent rate of 23S rDNA mutation of Hp nikramycin gene detected by nucleic acid assay was 91.67%,and that of 261A and 271T mutation of Hp levofloxacin resistance gene detected by nucleic acid assay was 96.67%.Conclusion Hp resistance to clarithromycin and levofloxacin had exceeded 70%.As a result,it was not recommended to use it in the treatment of patients who have failed the first eradication treatment in Zibo.Nucleic acid testing for Hp and resistance genes was consistent with culture,and it can be used for rapid detection of resistance to clarithromycin and levofloxacin.

Helicobacter pyloriResistanceResistance genesClarithromycinLevofloxacin

王萍、李时光、陈群、丰新倩、李庆

展开 >

淄博市第一医院检验科,淄博市分子免疫检验医学重点实验室,淄博 255200

淄博市第一医院消化内科,淄博 255200

幽门螺杆菌 耐药性 耐药基因 克拉霉素 左氧氟沙星

山东省医药卫生科技发展计划项目山东省医药卫生科技发展计划项目淄博市医药卫生科研项目

sdLDL-C2018WS00820231800128

2024

中国抗生素杂志
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

中国抗生素杂志

CSTPCD北大核心
影响因子:1.08
ISSN:1001-8689
年,卷(期):2024.49(9)